Documentos de Parodi C.M. | REDI

Regresar

Mostrando 7 resultados de: 7

Filtros aplicados

Área temáticas: "Enfermedades"

Subtipo de publicación

Publisher

Medicina (Argentina)(2)

Acta Tropica(1)

Journal of Parasitology(1)

Medical Microbiology and Immunology(1)

PLoS Neglected Tropical Diseases(1)

Área temáticas

Medicina forense; incidencia de enfermedades(3)

Farmacología y terapéutica(2)

Microorganismos, hongos y algas(2)

Ginecología, obstetricia, pediatría, geriatría(1)

Medicina y salud(1)

Área de conocimiento

Inmunología(3)

Epidemiología(1)

Farmacología(1)

Parasitología(1)

Año de Publicación

Origen

Palabras Claves

Cutaneous leishmaniasis(3)

Mucocutaneous leishmaniasis(3)

Visceral leishmaniasis(2)

B lymphocytes(1)

B-cell activating factor(1)

Clinical and epidemiological features of leishmaniasis in northwestern-Argentina through a retrospective analysis of recent cases

Abstract: Leishmaniasis is a parasitic disease caused by hemoflagellates of the genus Leishmania and is transm

Palabras claves:

Cutaneous leishmaniasis, Leishmania (L.) amazonensis, Leishmania (L.) infantum, Leishmania (V.) braziliensis, Mucocutaneous leishmaniasis, Visceral leishmaniasis

Alejandra Beatriz Barrio, Basombŕo M.A., Beckar J., Fabricio Miguel Locatelli, González-Prieto G., Hashiguchi Y., Jaime D., Jorge Diego Marco, María Celia Mora, María Fernanda García Bustos, Monroig S., Moreno S., Parodi C.M., Ramos F., Sajama J., Yeo M.

B-cell profile, B-cell activating factor concentration and IgG levels in human cutaneous and mucosal leishmaniasis

Abstract: Aims: The aim of this study was to evaluate characteristics of B cells in human tegumentary leismani

Palabras claves:

B lymphocytes, B-cell activating factor, Cutaneous leishmaniasis, hypergammaglobulinemia, interferon-gamma, Interleukin-6, Mucocutaneous leishmaniasis

Albareda M.C., Alejandra Beatriz Barrio, Badano N., Castro Eiro M.E., de Elizalde de Bracco M.M., González Prieto A.G., Laucella S.A., María Fernanda García Bustos, Parodi C.M., Pimentel J.

Alterations of immunological parameters in an autochthonous case of visceral leishmaniasis from the northwest of Argentina

Abstract: We report the alterations of immunological parameters of a patient with visceral leishmaniasis cause

Palabras claves:

B-lymphocyte differentiation, cytokines, T-lymphocyte differentiation, Visceral leishmaniasis

Alejandra Beatriz Barrio, Basombŕo M.A., de Bracco M.M.d.E., María Celia Mora, María Fernanda García Bustos, Parodi C.M., Ramos F.

American tegumentary leishmaniasis: T-cell differentiation profile of cutaneous and mucosal forms—co-infection with Trypanosoma cruzi

Abstract: American tegumentary leishmaniasis displays two main clinical forms: cutaneous (CL) and mucosal (ML)

Palabras claves:

Cutaneous leishmaniasis, Differentiation and memory phenotype, Leishmania–T. cruzi co-infection, Mucosal leishmaniasis, Peripheral T lymphocytes

Alejandra Beatriz Barrio, Baré P., Basombŕo M.A., de Elizalde de Bracco M.M., González Prieto A.G., María Celia Mora, María Fernanda García Bustos, Parodi C.M., Ramos F.

In vivo antileishmanial efficacy of miltefosine against Leishmania (Leishmania) amazonensis

Abstract: Leishmaniasis, a disease caused by parasites of the Leishmania genus, constitutes a significant heal

Palabras claves:

Alejandra Beatriz Barrio, Basombŕo M.A., Cimino R.O., De Raspi E.M., María Fernanda García Bustos, Parada L.A., Parodi C.M., Prieto G.G., Rubén Marino Cardozo, Soto J., Uncos D.A., Yeo M.

Miltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis

Abstract: The conventional treatment for tegumentary leishmaniasis is meglumine antimoniate, which needs paren

Palabras claves:

Leishmaniasis treatment, Miltefosine, Mucocutaneous leishmaniasis

Alejandra Beatriz Barrio, Basombŕo M.A., Beckar J., María Fernanda García Bustos, Moreno S., Parodi C.M.

Risk factors for antimony treatment failure in american cutaneous leishmaniasis in Northwestern-Argentina

Abstract: Background. To date, there is no specific literature available on the determinants for therapeutic f

Palabras claves:

Alejandra Beatriz Barrio, Beckar J., Delgado-Noguera L.A., González-Prieto G., Hashiguchi Y., Jaime D., Lemir C.G., María Celia Mora, María Fernanda García Bustos, Monroig S., Moreno S., Oliveira F., Pániz-Mondolfi A.E., Parodi C.M., Ramos F., Ruiz-Morales L.